Litigation Details for EVOKE PHARMA, INC. v. TEVA PHARMACEUTICALS INC. (D.N.J. 2022)
✉ Email this page to a colleague
EVOKE PHARMA, INC. v. TEVA PHARMACEUTICALS INC. (D.N.J. 2022)
Docket | ⤷ Sign Up | Date Filed | 2022-04-07 |
Court | District Court, D. New Jersey | Date Terminated | 2023-01-29 |
Cause | 15:1126 Patent Infringement | Assigned To | Renee Marie Bumb |
Jury Demand | None | Referred To | Sharon A. King |
Parties | TEVA PHARMACEUTICALS INC. | ||
Patents | 8,334,281 | ||
Attorneys | LIZA M. WALSH | ||
Firms | Saiber, LLC | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in EVOKE PHARMA, INC. v. TEVA PHARMACEUTICALS INC.
Details for EVOKE PHARMA, INC. v. TEVA PHARMACEUTICALS INC. (D.N.J. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2022-04-07 | 1 | Complaint | action for patent infringement of United States Patent Nos. 8,334,281 (“the ’281 patent”) and 11,020,361…11,020,361 (“the ’361 patent”) (collectively, the “GIMOTI® Patents”) under the patent laws of the United…and ’361 patents. 32. The ’281 patent expires May 16, 2030, and the ’361 patent expires … PATENTS-IN-SUIT 23. The ’281 patent, entitled “Nasal Formulations…United States Patent Application No. 12/645,108. A true and correct copy of the ’281 patent is attached | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |